{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:31:38Z","timestamp":1772753498900,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10822-013-9687-x","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T05:37:32Z","timestamp":1383197852000},"page":"897-915","source":"Crossref","is-referenced-by-count":12,"title":["Fragment-based strategy for structural optimization in combination with 3D-QSAR"],"prefix":"10.1007","volume":"27","author":[{"given":"Haoliang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihe","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haichun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"9687_CR1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-381274-2.00006-6","volume":"493","author":"RL Desjarlais","year":"2011","unstructured":"Desjarlais RL (2011) Using computational techniques in fragment-based drug discovery. Methods Enzymol 493:137\u2013155","journal-title":"Methods Enzymol"},{"key":"9687_CR2","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.2174\/092986712803530467","volume":"19","author":"A Kumar","year":"2012","unstructured":"Kumar A, Voet A, Zhang KY (2012) Fragment based drug design: from experimental to computational approaches. Curr Med Chem 19:5128\u20135147","journal-title":"Curr Med Chem"},{"key":"9687_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrd3926","volume":"12","author":"M Baker","year":"2013","unstructured":"Baker M (2013) Fragment-based lead discovery grows up. Nat Rev Drug Discov 12:5\u20137","journal-title":"Nat Rev Drug Discov"},{"key":"9687_CR4","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2174\/156802607782194725","volume":"7","author":"HO Villar","year":"2007","unstructured":"Villar HO, Hansen MR (2007) Computational techniques in fragment based drug discovery. Curr Top Med Chem 7:1509\u20131513","journal-title":"Curr Top Med Chem"},{"key":"9687_CR5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10822-009-9284-1","volume":"23","author":"R Law","year":"2009","unstructured":"Law R, Barker O, Barker JJ, Hesterkamp T, Godemann R, Andersen O, Fryatt T, Courtney S, Hallett D, Whittaker M (2009) The multiple roles of computational chemistry in fragment-based drug design. J Comput Aided Mol Des 23:459\u2013473","journal-title":"J Comput Aided Mol Des"},{"key":"9687_CR6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/med.21255","volume":"33","author":"C Sheng","year":"2013","unstructured":"Sheng C, Zhang W (2013) Fragment informatics and computational fragment-based drug design: an overview and update. Med Res Rev 33:554\u2013598","journal-title":"Med Res Rev"},{"key":"9687_CR7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1021\/ci200003c","volume":"51","author":"H Yuan","year":"2011","unstructured":"Yuan H, Lu T, Ran T, Liu H, Lu S, Tai W, Leng Y, Zhang W, Wang J, Chen Y (2011) Novel strategy for three-dimensional fragment-based lead discovery. J Chem Inf Model 51:959\u2013974","journal-title":"J Chem Inf Model"},{"key":"9687_CR8","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1021\/jm040031v","volume":"47","author":"DA Erlanson","year":"2004","unstructured":"Erlanson DA, McDowell RS, O\u2019Brien T (2004) Fragment-based drug discovery. J Med Chem 47:3463\u20133482","journal-title":"J Med Chem"},{"key":"9687_CR9","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1021\/ja00226a005","volume":"110","author":"RD Cramer","year":"1988","unstructured":"Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110:5959\u20135967","journal-title":"J Am Chem Soc"},{"key":"9687_CR10","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"G Klebe","year":"1994","unstructured":"Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130\u20134146","journal-title":"J Med Chem"},{"key":"9687_CR11","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1021\/jm200112k","volume":"54","author":"JD Katz","year":"2011","unstructured":"Katz JD, Jewell JP, Guerin DJ, Lim J, Dinsmore CJ, Deshmukh SV, Pan BS, Marshall CG, Lu W, Altman MD, Dahlberg WK, Davis L, Falcone D, Gabarda AE, Hang G, Hatch H, Holmes R, Kunii K, Lumb KJ, Lutterbach B, Mathvink R, Nazef N, Patel SB, Qu X, Reilly JF, Rickert KW, Rosenstein C, Soisson SM, Spencer KB, Szewczak AA, Walker D, Wang W, Young J, Zeng Q (2011) Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer. J Med Chem 54:4092\u20134108","journal-title":"J Med Chem"},{"key":"9687_CR12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1871520611009010007","volume":"10","author":"TL Underiner","year":"2010","unstructured":"Underiner TL, Herbertz T, Miknyoczki SJ (2010) Discovery of small molecule c-Met inhibitors: evolution and profiles of clinical candidates. Anticancer Agents Med Chem 10:7\u201327","journal-title":"Anticancer Agents Med Chem"},{"key":"9687_CR13","doi-asserted-by":"crossref","first-page":"4408","DOI":"10.1158\/0008-5472.CAN-06-4443","volume":"67","author":"HY Zou","year":"2007","unstructured":"Zou HY, Li Q, Lee JH, Arango ME, McDonnell SR, Yamazaki S, Koudriakova TB, Alton G, Cui JJ, Kung PP, Nambu MD, Los G, Bender SL, Mroczkowski B, Christensen JG (2007) An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms. Cancer Res 67:4408\u20134417","journal-title":"Cancer Res"},{"key":"9687_CR14","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1074\/jbc.M705774200","volume":"283","author":"SF Bellon","year":"2008","unstructured":"Bellon SF, Kaplan-Lefko P, Yang Y, Zhang Y, Moriguchi J, Rex K, Johnson CW, Rose PE, Long AM, O\u2019Connor AB, Gu Y, Coxon A, Kim TS, Tasker A, Burgess TL, Dussault I (2008) c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations. J Biol Chem 283:2675\u20132683","journal-title":"J Biol Chem"},{"key":"9687_CR15","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1158\/0008-5472.CAN-09-2541","volume":"70","author":"BS Pan","year":"2010","unstructured":"Pan BS, Chan GK, Chenard M, Chi A, Davis LJ, Deshmukh SV, Gibbs JB, Gil S, Hang G, Hatch H, Jewell JP, Kariv I, Katz JD, Kunii K, Lu W, Lutterbach BA, Paweletz CP, Qu X, Reilly JF, Szewczak AA, Zeng Q, Kohl NE, Dinsmore CJ (2010) MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor. Cancer Res 70:1524\u20131533","journal-title":"Cancer Res"},{"key":"9687_CR16","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1038\/sj.onc.1207691","volume":"23","author":"S Berthou","year":"2004","unstructured":"Berthou S, Aebersold DM, Schmidt LS, Stroka D, Heigl C, Streit B, Stalder D, Gruber G, Liang C, Howlett AR, Candinas D, Greiner RH, Lipson KE, Zimmer Y (2004) The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants. Oncogene 23:5387\u20135393","journal-title":"Oncogene"},{"key":"9687_CR17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/0008-5472.CAN-10-1623","volume":"71","author":"J Qi","year":"2011","unstructured":"Qi J, McTigue MA, Rogers A, Lifshits E, Christensen JG, Janne PA, Engelman JA (2011) Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors. Cancer Res 71:1081\u20131091","journal-title":"Cancer Res"},{"key":"9687_CR18","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4161\/cc.7.9.5827","volume":"7","author":"I Dussault","year":"2008","unstructured":"Dussault I, Bellon SF (2008) c-Met inhibitors with different binding modes: two is better than one. Cell Cycle 7:1157\u20131160","journal-title":"Cell Cycle"},{"key":"9687_CR19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"CA Lipinski","year":"2004","unstructured":"Lipinski CA (2004) Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 1:337\u2013341","journal-title":"Drug Discov Today Technol"},{"key":"9687_CR20","doi-asserted-by":"crossref","first-page":"11218","DOI":"10.1074\/jbc.M110.204404","volume":"286","author":"KW Rickert","year":"2011","unstructured":"Rickert KW, Patel SB, Allison TJ, Byrne NJ, Darke PL, Ford RE, Guerin DJ, Hall DL, Kornienko M, Lu J, Munshi SK, Reid JC, Shipman JM, Stanton EF, Wilson KJ, Young JR, Soisson SM, Lumb KJ (2011) Structural basis for selective small molecule kinase inhibition of activated c-Met. J Biol Chem 286:11218\u201311225","journal-title":"J Biol Chem"},{"key":"9687_CR21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/jm0302997","volume":"47","author":"M Kontoyianni","year":"2004","unstructured":"Kontoyianni M, McClellan LM, Sokol GS (2004) Evaluation of docking performance: comparative data on docking algorithms. J Med Chem 47:558\u2013565","journal-title":"J Med Chem"},{"key":"9687_CR22","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1021\/ci1000407","volume":"50","author":"M Sandor","year":"2010","unstructured":"Sandor M, Kiss R, Keseru GM (2010) Virtual fragment docking by Glide: a validation study on 190 protein-fragment complexes. J Chem Inf Model 50:1165\u20131172","journal-title":"J Chem Inf Model"},{"key":"9687_CR23","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","volume":"69","author":"T Halgren","year":"2007","unstructured":"Halgren T (2007) New method for fast and accurate binding-site identification and analysis. Chem Biol Drug Des 69:146\u2013148","journal-title":"Chem Biol Drug Des"},{"key":"9687_CR24","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1021\/jm030543u","volume":"47","author":"AC Pierce","year":"2004","unstructured":"Pierce AC, Rao G, Bemis GW (2004) BREED: generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease. J Med Chem 47:2768\u20132775","journal-title":"J Med Chem"},{"key":"9687_CR25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrd1467","volume":"3","author":"DC Rees","year":"2004","unstructured":"Rees DC, Congreve M, Murray CW, Carr R (2004) Fragment-based lead discovery. Nat Rev Drug Discov 3:660\u2013672","journal-title":"Nat Rev Drug Discov"},{"key":"9687_CR26","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1021\/jm400211f","volume":"56","author":"EA Larsson","year":"2013","unstructured":"Larsson EA, Jansson A, Ng FM, Then SW, Panicker R, Liu B, Sangthongpitag K, Pendharkar V, Tai SJ, Hill J, Dan C, Ho SY, Cheong WW, Poulsen A, Blanchard S, Lin GR, Alam J, Keller TH, Nordlund P (2013) Fragment-based ligand design of novel potent inhibitors of tankyrases. J Med Chem 56:4497\u20134508","journal-title":"J Med Chem"},{"key":"9687_CR27","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1021\/jm800382h","volume":"51","author":"PG Wyatt","year":"2008","unstructured":"Wyatt PG, Woodhead AJ, Berdini V, Boulstridge JA, Carr MG, Cross DM, Davis DJ, Devine LA, Early TR, Feltell RE, Lewis EJ, McMenamin RL, Navarro EF, O\u2019Brien MA, O\u2019Reilly M, Reule M, Saxty G, Seavers LC, Smith DM, Squires MS, Trewartha G, Walker MT, Woolford AJ (2008) Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design. J Med Chem 51:4986\u20134999","journal-title":"J Med Chem"},{"key":"9687_CR28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1021\/ci700424b","volume":"48","author":"F Dey","year":"2008","unstructured":"Dey F, Caflisch A (2008) Fragment-based de novo ligand design by multiobjective evolutionary optimization. J Chem Inf Model 48:679\u2013690","journal-title":"J Chem Inf Model"},{"key":"9687_CR29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1021\/cb300729y","volume":"8","author":"R Urich","year":"2013","unstructured":"Urich R, Wishart G, Kiczun M, Richters A, Tidten-Luksch N, Rauh D, Sherborne B, Wyatt PG, Brenk R (2013) De novo design of protein kinase inhibitors by in silico identification of hinge region-binding fragments. ACS Chem Biol 8:1044\u20131052","journal-title":"ACS Chem Biol"},{"key":"9687_CR30","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ejmech.2013.01.023","volume":"62","author":"H Chen","year":"2013","unstructured":"Chen H, Yang Z, Ding C, Chu L, Zhang Y, Terry K, Liu H, Shen Q, Zhou J (2013) Fragment-based drug design and identification of HJC0123, a novel orally bioavailable STAT3 inhibitor for cancer therapy. Eur J Med Chem 62:498\u2013507","journal-title":"Eur J Med Chem"},{"key":"9687_CR31","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/jm8000373","volume":"51","author":"M Congreve","year":"2008","unstructured":"Congreve M, Chessari G, Tisi D, Woodhead AJ (2008) Recent developments in fragment-based drug discovery. J Med Chem 51:3661\u20133680","journal-title":"J Med Chem"},{"key":"9687_CR32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1124\/mi.9.1.7","volume":"9","author":"M Fischer","year":"2009","unstructured":"Fischer M, Hubbard RE (2009) Fragment-based ligand discovery. Mol Interv 9:22\u201330","journal-title":"Mol Interv"},{"key":"9687_CR33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00126839-200809040-00002","volume":"9","author":"D Fattori","year":"2008","unstructured":"Fattori D, Squarcia A, Bartoli S (2008) Fragment-based approach to drug lead discovery: overview and advances in various techniques. Drugs R D 9:217\u2013227","journal-title":"Drugs R D"},{"key":"9687_CR34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/128_2011_182","volume":"317","author":"D Rognan","year":"2012","unstructured":"Rognan D (2012) Fragment-based approaches and computer-aided drug discovery. Top Curr Chem 317:201\u2013222","journal-title":"Top Curr Chem"},{"key":"9687_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/prot.22028","volume":"73","author":"P Kolb","year":"2008","unstructured":"Kolb P, Kipouros CB, Huang D, Caflisch A (2008) Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors. Proteins 73:11\u201318","journal-title":"Proteins"},{"issue":"3","key":"9687_CR36","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/ci300502h","volume":"53","author":"T Zhu","year":"2013","unstructured":"Zhu T, Lee H, Lei H, Jones C, Patel K, Johnson ME, Hevener KE (2013) Fragment-based drug discovery using a multidomain, parallel MD-MM\/PBSA screening protocol. J Chem Inf Model 53(3):560\u2013572","journal-title":"J Chem Inf Model"},{"key":"9687_CR37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11030-012-9405-y","volume":"16","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Liu H, Jiao Y, Yuan H, Wang F, Lu S, Yao S, Ke Z, Tai W, Jiang Y, Chen Y, Lu T (2012) De novo design of N-(pyridin-4-ylmethyl)aniline derivatives as KDR inhibitors: 3D-QSAR, molecular fragment replacement, protein\u2013ligand interaction fingerprint, and ADMET prediction. Mol Divers 16:787\u2013802","journal-title":"Mol Divers"},{"key":"9687_CR38","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1021\/jm301619u","volume":"56","author":"AB Northrup","year":"2013","unstructured":"Northrup AB, Katcher MH, Altman MD, Chenard M, Daniels MH, Deshmukh SV, Falcone D, Guerin DJ, Hatch H, Li C, Lu W, Lutterbach B, Allison TJ, Patel SB, Reilly JF, Reutershan M, Rickert KW, Rosenstein C, Soisson SM, Szewczak AA, Walker D, Wilson K, Young JR, Pan BS, Dinsmore CJ (2013) Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): a specific c-Met\/Ron dual kinase inhibitor with preferential affinity for the activated state of c-Met. J Med Chem 56:2294\u20132310","journal-title":"J Med Chem"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9687-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-013-9687-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9687-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T21:23:14Z","timestamp":1559251394000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-013-9687-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9687"],"URL":"https:\/\/doi.org\/10.1007\/s10822-013-9687-x","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}